Allogenic bone marrow mesenchymal stem cell therapy - Cellgenes Biotechnology
Alternative Names: CG BM1Latest Information Update: 21 Feb 2025
At a glance
- Originator Unknown
- Class Mesenchymal stem cell therapies
- Mechanism of Action Cell replacements
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Phase II Liver failure